Inventor · disambiguated record
Stephanie Erbar
Also filed as: ERBAR STEPHANIE
2 granted patents·11 pending applications·1 citations·filing 2017–2024
36Inventor score
Top patents by PatentIndex Score
13 records- 0177US11318195B2Formulation for administration of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 0271US2025213599A1Formulation for administration of rnaBioNTech SE·Filed 2024·Application pending·0 cites
- 0363US12150947B2Formulation for administration of RNABioNTech SE·Filed 2019·Granted Nov 26, 2024·0 cites·16 claims
- 0463US2022313811A1Formulation for administration of rnaBioNTech SE·Filed 2022·Application pending·0 cites
- 0560US2025281602A1Replicon Compositions and Methods of Using Same for the Treatment of DiseasesBioNTech SE·Filed 2023·Application pending·0 cites
- 0657US2025027066A1Rna encoding peptidoglycan hydrolase and use thereof for treating bacterial infectionBioNTech SE·Filed 2022·Application pending·0 cites
- 0757US2025375534A1Complexes for delivery of nucleic acidsBioNTech SE·Filed 2023·Application pending·0 cites
- 0855US2025057960A1Oligosaccharide complexes and usesBioNTech SE·Filed 2022·Application pending·0 cites
- 0952US2025057944A1Oligosaccharide complexes and usesBioNTech SE·Filed 2022·Application pending·0 cites
- 1051US2024417418A1Disulfide oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 1151US2025002522A1Oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 1251US2024425541A1Oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 1343US2022362388A1Rna formulations suitable for therapyBioNTech SE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephanie Erbar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →